(2-246) Ascorbic Acid’s Use in Reducing the Incidence of Methemoglobinemia in Patients Treated with Inhaled Nitric Oxide in ARDS/COVID19

Monday, December 5, 2022

10:45 AM – 11:45 AM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Critical Care

Co-Author(s): Tyler Bui

Primary Author(s)

Talia M. LaSpina
University of Florida College of Pharmacy - Orlando Campus, Florida